Welcome to Chinese Journal of Clinical Pharmacology and Therapeutics,Today is Share:

Chinese Journal of Clinical Pharmacology and Therapeutics ›› 2020, Vol. 25 ›› Issue (12): 1351-1356.doi: 10.12092/j.issn.1009-2501.2020.12.005

Previous Articles     Next Articles

Identification of myelodysplastic syndromes related long noncoding RNA by bioinformatics

LIU Jianhui 1, ZHOU Genhong 1, LI Chunlin 1, BAO Meihua 2, LIU Fangyi 2   

  1. 1 Hunan General Hospital of Armed Police, Changsha 410006, Hunan, China; 2 Academician Workstation, Changsha 410219, Hunan, China 
  • Received:2020-06-18 Revised:2020-11-02 Online:2020-12-26 Published:2021-01-04

Abstract: AIM: To identify the differentially expressed lncRNAs related to myelodysplastic syndromes by method of bioinformatics.  METHODS: The GSE145733 was downloaded from GEO database; the differentially expressed lncRNAs were screened out by GEO2R. miRNA and mRNA associated with the differentially expressed lncRNAs were analyzed by the platform miRDB. lncRNA-miRNA-mRNA network was constructed and visualized by Cytoscape software. We annotated and enriched the lncRNAs to biological functions and pathways by GO and KEGG tools. RESULTS: Five differentially expressed lncRNAs were screened out. These lncRNAs were associated with 19 miRNAs and 84 mRNAs. They mainly affected the functions such as substance synthesis and transportation, gene transcription, and nervous system. CONCLUSION: We discovered the lncRNA expression characteristics in MDS patients, predicted the functions of these lncRNAs, which may provide new drug targets for the precise medication in MDS. 

Key words: myelodysplastic syndromes, long noncoding RNA, differentially expressed genes, bioinformatics

CLC Number: